CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

[Pharmaceuticals][Biotechnology][News Releases in Similar Topics]---- -- CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments [Accessibility Statement] Skip NavigationNext-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapiesREHOVOT, Israel, Feb. 17, 2026 /PRNewswire/ -- [CollPlant Biotechnologies](NASDAQ: CLGN), a regenerative and aesthetic medicine company developing ...